Balance Sheet Components - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Balance Sheet Related Disclosures [Abstract] | ||||
| Depreciation and amortization expense | $ 1,700 | $ 2,100 | $ 3,500 | $ 4,700 |
| Impairment loss | 21,821 | 21,821 | $ 0 | |
| Leasehold improvements, manufacturing and laboratory equipment | $ 0 | $ 0 | ||
| X | ||||||||||
- Definition Leasehold improvements, manufacturing and laboratory equipment. No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|